Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis-Reference-Cited by-同舟云学术

Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis

Published:2020-07 Issue: Volume:253 Page:117572
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Tao Le,Wu Liu,Zhang Wei,Ma Wen-ting,Yang Guang-yue,Zhang Jie,Xue Dong-ying,Chen Bei,Liu Cheng

Funder

National Natural Science Foundation of China

Peak Discipline of Colleges and Universities in Shanghai

Putuo Hospital

Shanghai University of Traditional Chinese Medicine

Health System Independent Innovation Science Foundation of Shanghai Putuo District

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference30 articles.

1. Fibrogenic activity of mecp2 is regulated by phosphorylation in hepatic stellate cells;Moran-Salvador;Gastroenterology,2019

2. Glial cell line-derived neurotrophic factor (gdnf) mediates hepatic stellate cell activation via alk5/smad signalling;Tao;Gut,2019

3. Recent advancement of molecular mechanisms of liver fibrosis;Seki;J. Hepatobiliary Pancreat. Sci.,2015

4. P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts;Dou;Gastroenterology,2018

5. Hepatic interferon regulatory factor 6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing peroxisome proliferator-activated receptor gamma in mice;Tong;Hepatology,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic Signaling in Non-Parenchymal Liver Cells;International Journal of Molecular Sciences;2024-08-30

2. Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways;Prostaglandins & Other Lipid Mediators;2024-08

3. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

4. The Up-Regulation of miR-146a and miR-29b via Exosomes Protects Against Liver Fibrosis by Inhibiting the TGF-β/Smad3c Signaling Pathway;Hepatitis Monthly;2024-06-19

5. Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats;Experimental and Clinical Endocrinology & Diabetes;2024-05-08